Holen Sie sich die Stockscreener-App
80.81
5.21%
4.005
Schlusskurs vom Vortag:
$76.81
Offen:
$82.25
24-Stunden-Volumen:
21,527
Relative Volume:
0.38
Marktkapitalisierung:
$1.03B
Einnahmen:
$69.48M
Nettoeinkommen (Verlust:
$18.64M
KGV:
55.35
EPS:
1.46
Netto-Cashflow:
$13.01M
1W Leistung:
+3.97%
1M Leistung:
+13.44%
6M Leistung:
+51.14%
1J Leistung:
+67.32%
1-Tages-Spanne:
$77.72
$82.25
1-Wochen-Bereich:
$75.75
$82.25
52-Wochen-Spanne:
$47.48
$82.25
Iradimed Corp Stock (IRMD) Company Profile
Firmenname
Iradimed Corp
Sektor
Branche
Telefon
(407) 677-8022
Adresse
12705 INGENUITY DRIVE, ORLANDO
Vergleichen Sie IRMD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRMD
Iradimed Corp
|
80.81 | 977.02M | 69.48M | 18.64M | 13.01M | 1.46 |
|
ABT
Abbott Laboratories
|
122.56 | 214.96B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.11 | 149.24B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
SYK
Stryker Corp
|
355.40 | 136.23B | 24.38B | 2.94B | 4.02B | 7.6145 |
|
MDT
Medtronic Plc
|
89.08 | 116.33B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
80.39 | 48.41B | 5.88B | 1.34B | 577.90M | 2.3455 |
Iradimed Corp Stock (IRMD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-04-12 | Eingeleitet | Lake Street | Buy |
| 2017-10-31 | Fortgesetzt | ROTH Capital | Buy |
| 2016-10-05 | Herabstufung | ROTH Capital | Buy → Neutral |
| 2015-11-02 | Bestätigt | ROTH Capital | Buy |
| 2015-07-30 | Bestätigt | ROTH Capital | Buy |
| 2015-06-16 | Bestätigt | ROTH Capital | Buy |
| 2015-01-12 | Bestätigt | ROTH Capital | Buy |
| 2014-12-23 | Bestätigt | ROTH Capital | Buy |
Alle ansehen
Iradimed Corp Aktie (IRMD) Neueste Nachrichten
IRadimed’s Record Quarter Lands On Wall Street’s Buy List - Finimize
Iradimed Lifts Forecasts As Q3 Results Top Expectations - Finimize
Iradimed Corporation Reports Record Q3 2025 Revenue of $21.2 Million and Raises Full-Year Guidance - Quiver Quantitative
IRadimed: Q3 Earnings Snapshot - MarketScreener
IRADIMED CORPORATION Reports Record Third Quarter 2025 Financial Results - TradingView
Using R and stats models for IRADIMED CORPORATION forecastingWeekly Trade Recap & High Return Trade Opportunity Guides - newser.com
Will IRADIMED CORPORATION (46K) stock beat growth indexesTrade Performance Summary & Verified Momentum Stock Alerts - newser.com
Published on: 2025-11-02 11:55:05 - newser.com
Leading vs lagging indicators on IRADIMED CORPORATION performanceJuly 2025 Summary & Daily Stock Trend Reports - newser.com
iRadimed (NASDAQ:IRMD) Rating Increased to Strong-Buy at Roth Capital - MarketBeat
iRadimed (IRMD) Expected to Announce Earnings on Monday - Defense World
iRadimed's (IRMD) Buy (B) Rating Reaffirmed at Weiss Ratings - MarketBeat
What recovery options are there for IRADIMED CORPORATION2025 Breakouts & Breakdowns & Low Drawdown Momentum Ideas - newser.com
Historical volatility pattern of IRADIMED CORPORATION visualizedQuarterly Earnings Summary & AI Powered Buy and Sell Recommendations - newser.com
iRadimed Corp (IRMD) Q3 2025 Earnings Report Preview: What to Look For - Yahoo Finance
iRadimed Corp (IRMD) Q3 2025 Earnings Report Preview: What to Lo - GuruFocus
Can IRADIMED CORPORATION stock sustain revenue growthQuarterly Risk Review & Daily Oversold Bounce Ideas - newser.com
iRadimed (IRMD) Coverage Resumed with Positive Outlook by Roth C - GuruFocus
iRadimed (NASDAQ:IRMD) CEO Sells $388,450.00 in Stock - MarketBeat
iRadimed (NASDAQ:IRMD) Sets New 12-Month HighShould You Buy? - MarketBeat
Analyzing recovery setups for IRADIMED CORPORATION investorsWeekly Earnings Recap & Expert Approved Trade Ideas - newser.com
IRADIMED Earnings Preview: Recent $IRMD Insider Trading, Hedge Fund Activity, and More - Quiver Quantitative
IRadimed Corp. Hits New 52-Week High of $79.14, Up 84.64% - Markets Mojo
Developing predictive dashboards with IRADIMED CORPORATION data2025 Sector Review & Low Risk High Win Rate Picks - newser.com
IRadimed Corp. Experiences Evaluation Revision Amid Strong Market Performance and Dynamics - Markets Mojo
How supply shortages influence IRADIMED CORPORATION (46K) stockJuly 2025 Action & Weekly Return Optimization Alerts - newser.com
Can IRADIMED CORPORATION stock deliver surprise earnings beatTrade Risk Assessment & Consistent Growth Equity Picks - newser.com
Ranking IRADIMED CORPORATION among high performing stocks via toolsWeekly Trend Summary & Free Technical Confirmation Trade Alerts - newser.com
Iradimed Corporation to Release 2025 Third Quarter Financial Results on November 3, 2025 - Quiver Quantitative
IRADIMED (NASDAQ: IRMD) sets Nov. 3 results release; conference call 11 a.m. ET - Stock Titan
Why IRADIMED CORPORATION stock is trending among retail traders2025 Macro Impact & Weekly Return Optimization Plans - fcp.pa.gov.br
IRadimed Corp expected to post earnings of 46 cents a shareEarnings Preview - TradingView
Can volume confirm reversal in IRADIMED CORPORATIONQuarterly Growth Report & AI Powered Market Entry Ideas - newser.com
Will IRADIMED CORPORATION (46K) stock profit from fiscal stimulusJuly 2025 Recap & Capital Protection Trade Alerts - newser.com
How IRADIMED CORPORATION stock trades during market volatilityGlobal Markets & High Return Stock Watch Alerts - newser.com
Will IRADIMED CORPORATION stock deliver consistent dividendsQuarterly Risk Review & AI Based Buy and Sell Signals - newser.com
Institutional scanner results for IRADIMED CORPORATION2025 Macro Impact & Weekly Momentum Stock Picks - newser.com
Analyzing IRADIMED CORPORATION with risk reward ratio chartsJuly 2025 WrapUp & Risk Adjusted Swing Trade Ideas - newser.com
IRadimed Corp. Experiences Valuation Adjustment Amid Strong Market Performance and Competitive Positioning - Markets Mojo
Shaker Investments LLC OH Purchases 9,580 Shares of iRadimed Corporation $IRMD - MarketBeat
Will IRADIMED CORPORATION stock remain a Wall Street favoriteNew Guidance & Safe Entry Point Alerts - newser.com
iRadimed (NASDAQ:IRMD) Cut to Buy at Wall Street Zen - MarketBeat
Finanzdaten der Iradimed Corp-Aktie (IRMD)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.69%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):